Asthma
COPD
Respiratory Infections
Cystic Fibrosis
Interstital Lung Disease
Respiratory Malignancies
Rhinitis
Articles
Congress Reports
Clinical Scenarios
Expert Interviews
Quick Vote
Ask the Expert
RespiBlog
Event Calendar
News
Links
RSS
Searching...
Which statement would you consider the most accurate with regard to airway inflammation in cystic fibrosis?
Neutrophilic airway inflammation results from proinflammatory mutations
Inflammation is mostly secondary to infections
Regardless of its cause, inflammation is a risk factor for lung function decline and should be actively monitored and treated
All of the above are relevant and should be considered independently but concomitantly
 
Urinary incontinence inversely correlated with respiratory function
June 23, 2009
TAL-6004 reported to be safe and well tolerated in alpha1-antitrypsin deficiency emphysema
June 04, 2009
Single doses of MEDI-528 do not affect allergen responses in asthma patients
June 01, 2009
Clinical data on inhaled, intravenous alpha-1 antitrypsin presented
May 29, 2009
CAT-354, an anti-IL-13 human monoclonal antibody for asthma therapy, deemed safe in healthy subjects
May 27, 2009
A variant in TCF7L2 increases the risk of type 2 diabetes in patients with cystic fibrosis
May 19, 2009
Articles
The Mediterranean Diet, Part I: The Anticancer Effect of Olive Oil
Ernest Pauwels, M.I. Covas
July 01, 2009
Congress Reports
The Fight Against Cancer Continues: A Report from the 45th Annual Meeting of the American Society of Clinical Oncology
June 18, 2009
Congress Reports
Breathing Easy Under the Purple Shadow: A Report from the American Thoracic Society 2009 International Conference
May 25, 2009
RespiBlog
Requests for Experience with Anti-IgE Therapy
Trevor T. Hansel, Peter J. Barnes
December 19, 2008
RespiBlog
The Role of Exhaled NO or Sputum Eosinophils in the Management of Patients with Asthma
Trevor T. Hansel, Peter J. Barnes
December 01, 2008
Ask the Expert
Pulmonary Rehabilitation
Enrico M. Clini
August 08, 2008
© Copyright
2009
Prous Science S.A.U.
a Thomson Reuters business or its licensors. All rights reserved.
Legal Information
. Send your comments to
Webmaster
ISSN 1887-3375
We comply with the HONcode standard for
health trust worthy information: verify here
.